Back to Search
NANANAMIBIA DUFFY, M.D.
M.D.
Dermatology Physician
NPI: 1700918950IndividualAccepts Medicare
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 2006
Research & Publications (20)
BMP13 prevents the effects of annular injury in an ovine model.
PMID 19521550·Int J Biol Sci·2009
7-preclinical
Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD.
PMID 19164347·Eur Respir J·2009
8-other
Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects.
PMID 17904681·Diabetes Res Clin Pract·2008
8-other
Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.
PMID 17603023·Biochem Pharmacol·2007
8-other
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
PMID 17573070·Eur J Pharmacol·2007
7-preclinical
Expiratory flow limitation detected by forced oscillation and negative expiratory pressure.
PMID 17079262·Eur Respir J·2007
4-observational
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
PMID 16945366·Eur J Pharmacol·2006
7-preclinical
Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues.
PMID 16480266·J Med Chem·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 WHITE SPRUCE BLVD
ROCHESTER, NY 14623 - Phone
- (585) 424-6770
Quick Facts
- NPI
- 1700918950
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 20
- Publications
- 20
Are you this provider?
Claim Your Profile